Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research

Core Insights - Azenta, Inc. has been selected by the Crohn's & Colitis Foundation as the sample management services provider for two significant research cohorts, CAPTURE IBD and IBD SIRQC, focusing on pediatric and surgical care for inflammatory bowel disease [1][2] - The CAPTURE IBD study aims to enroll several thousand pediatric patients across 12 sites in the U.S., while the IBD SIRQC initiative plans to enroll 5,000 patients at 9 sites, tracking long-term surgical outcomes [2][3] - The partnership is expected to enhance the understanding of inflammatory bowel disease and support the development of precision medicine strategies [3] Company Overview - Azenta, Inc. is a leading provider of life sciences solutions, offering a comprehensive suite of cold-chain sample management and multiomics services to pharmaceutical, biotech, academic, and healthcare institutions globally [5] - The company is headquartered in Burlington, Massachusetts, with operations in North America, Europe, and Asia, and is known for its brands including GENEWIZ, FluidX, and others [5] Foundation Overview - The Crohn's & Colitis Foundation is a prominent nonprofit organization dedicated to research and patient support for inflammatory bowel disease, aiming to cure Crohn's disease and ulcerative colitis while improving the quality of life for affected individuals [4] - The Foundation's IBD Plexus® program provides a rich research ecosystem that links well-phenotyped data to biosamples, facilitating high-impact research [2][4]